New policy on high-risk biology studies aims to address criticism that previous rules were too vague https://t.co/V8HgRmQBbS
New U.S. policies for gain-of-function and “dual-use” research will cover a broader swath of experiments. https://t.co/zQ4A8Yth5e
White House unveils revised dual-use and pandemic pathogen research oversight policy The finalized policy was supported by the work of a federal advisory group, which had listening sessions to hear from stakeholders. https://t.co/XDbl9Wzk3F Photo: NIAID/Flickr cc https://t.co/RSmTRsM2b3
The White House has officially released a new policy aimed at regulating dual-use research and potential pandemic pathogen research, specifically targeting federally-funded studies. This policy, which has been long anticipated, seeks to address gaps in previous guidelines and provide clearer direction for research that could potentially make pathogens like the H5N1 avian influenza virus more dangerous. Despite intentions to enhance safety and oversight, several critics, including researchers and advisory bodies who conducted listening sessions from stakeholders, have expressed concerns that the policy's complexity and its narrow definition of 'potential pandemic pathogen' could exempt many studies from thorough risk-benefit analysis, potentially making the public less safe.